NKGen Biotech Inc. Common...

0.18
0.02 (11.94%)
At close: Mar 28, 2025, 3:35 PM
0.18
0.00%
After-hours: Mar 28, 2025, 03:35 PM EDT

NKGen Biotech Common Stock Income Statement

Year FY23 FY22 FY21
Revenue n/a 77K 426K
Cost of Revenue 1.2M 18K 30K
Gross Profit -1.2M 59K 396K
Operating Income -29.75M -24.35M -21.86M
Interest Income n/a n/a n/a
Pretax Income -82.95M -26.75M -23.26M
Net Income -82.95M -26.75M -23.27M
Selling & General & Admin 14.08M 7.66M 7.58M
Research & Development 14.46M 16.75M 14.67M
Other Expenses n/a -95K -84K
Operating Expenses 28.54M 24.41M 22.26M
Interest Expense 745K 2.31M 1.31M
Selling & Marketing Expenses n/a n/a n/a
Cost & Expenses 29.75M 24.42M 22.29M
Income Tax 7K 7K 5K
Shares Outstanding (Basic) 15.43M 6.36M 21.45M
Shares Outstanding (Diluted) 15.43M 6.36M 21.45M
EPS (Basic) -5.38 -4.21 -1.08
EPS (Diluted) -5.38 -4.21 -1.08
EBITDA -28.54M -23.23M -20.7M
Depreciation & Amortization 1.2M 1.21M 1.24M